LIPOCINE INC. License and Services Revenue (Deprecated 2018-01-31)
LIPOCINE INC. (LPCN) reported License and Services Revenue (Deprecated 2018-01-31) of $428.03 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2018-05-07
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $428.03K.
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00.
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- LIPOCINE INC. license and services revenue (deprecated 2018-01-31) for fiscal 2012 was $7.52M.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $428.03K 10-Q · filed 2018-05-07 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-07 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | ||
| 2012-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.00 derived: sum of 2 quarters · filed 2014-03-31 | $7.52M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-13 | $7.52M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |